bioRxivNeuroscience
A practical computerized decision support system for predicting the severity of Alzheimer’s disease of an individual
Magda BucholciD, Xuemei DingiD, Haiying WangiD, David H. GlassiD, Hui WangiD, Girijesh PrasadiD, Liam MaguireiD, Anthony J. BjoursoniD, Paula L. McCleaniD, Stephen ToddiD, David P. FinniD, KongFatt Wong‐LiniD, for the Alzheimer’s Disease Neuroimaging Initiative
Abstract
Computerized clinical decision support systems can help to provide objective, standardized, and timely dementia diagnosis. However, current computerized systems are mainly based on the group analysis, discrete classification of disease stages, or expensive and not readily accessible biomarkers, while current clinical practice relies relatively heavily on cognitive and functional assessments (CFA). In this study, we developed a computational framework using a suite of machine learning tools for identifying key markers in predicting the severity of Alzheimers disease (AD) from a large set of biological and clinical measures. Six machine learning approaches, namely Kernel Ridge Regression (KRR), Support Vector Regression (SVR), and k-Nearest Neighbor (kNNreg) for regression and Support Vector Machine (SVM), Random Forest (RF), and k-Nearest Neighbor (kNNclass) for classification, were used for the development of predictive models. We demonstrated high predictive power of CFA. Predictive performance of models incorporating CFA was shown to be consistently higher accuracy than those based solely on biomarker modalities. We found that KRR and SVM were the best performing regression and classification methods respectively. The optimal SVM performance was observed for a set of four CFA test scores (FAQ, ADAS13, MoCA, MMSE) with multi-class classification accuracy of 83.0%, 95%CI = (72.1%, 93.8%) while the best performance of the KRR model was reported with combined CFA and MRI neuroimaging data, i.e., R2 = 0.874, 95%CI = (0.827, 0.922). Given the high predictive power of CFA and their widespread use in clinical practice, we then designed a data-driven and self-adaptive computerized clinical decision support system (CDSS) prototype for evaluating the severity of AD of an individual on a continuous spectrum. The system implemented an automated computational approach for data pre-processing, modelling, and validation and used exclusively the scores of selected cognitive measures as data entries. Taken together, we have developed an objective and practical CDSS to aid AD diagnosis.
- Citations
- 106
- FWCI
- 10.73
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel Artificial Intelligence (AI) Method to Classify and Predict the Progression of Alzheimers Disease
Md Mehedi Hasan, Senjuti Rahman, … Suman Kanti Chowdhury·bioRxiv·Jun 3, 2024
- Multidomain Analysis of Clinical Cognitive Assessments and Imaging Data in Alzheimer's Disease Accurately Predicts Disease Stage and Grade Independent of Amyloid and Tau
Juan Antonio K. Chong Chie, Scott A. Persohn, … Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Apr 13, 2026
- MRI and cognitive scores complement each other to accurately predict Alzheimer’s dementia 2 to 7 years before clinical onset
Azar Zandifar, Vladimir Fonov, … for the Alzheimer’s Disease Neuroimaging Initiative·NeuroImage ClinicalPeer-reviewed·Dec 16, 2019
- Predicting Alzheimer's disease progression trajectory and clinical subtypes using machine learning
Vipul K. Satone, Rachneet Kaur, … Faraz Faghri·bioRxiv·Aug 26, 2020
- Identifying incident dementia by applying machine learning to a very large administrative claims dataset
Vijay S. Nori, Christopher A. Hane, … Darshak M. Sanghavi·PLoS ONEPeer-reviewed·Jul 5, 2019
- ArcheD, a residual neural network for prediction of cerebrospinal fluid amyloid-beta from amyloid PET images
Arina A. Tagmazian, Claudia Schwarz, … the Alzheimer’s Disease Neuroimaging Initiative·European Journal of NeurosciencePeer-reviewed·Apr 4, 2024